id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0147-0004,FDA,FDA-2002-D-0147,CVM GFI #132 Administrative Applications and the Phased Review Process,Other,Guidance,2018-05-23T04:00:00Z,2018,5,2018-05-23T04:00:00Z,,2024-11-07T01:30:46Z,,1,0,09000064832daf14
FDA-2002-D-0147-0002,FDA,FDA-2002-D-0147,"Administrative Applications and the Phased Review Process; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-05-06T04:00:00Z,2015,5,2015-05-06T04:00:00Z,,2015-05-06T15:13:11Z,2015-10480,0,0,0900006481ad0125
FDA-2002-D-0147-0003,FDA,FDA-2002-D-0147,"Administrative Applications and the Phased Review Process; Guidance for
Industry",Other,Guidance,2015-05-06T04:00:00Z,2015,5,2015-05-06T04:00:00Z,,2018-05-30T16:35:42Z,,0,0,0900006481ad0d77
FDA-2002-D-0147-0001,FDA,FDA-2002-D-0147,FDA,Notice,NAD-Notice of Availability of Data,2002-11-13T05:00:00Z,2002,11,2002-11-13T05:00:00Z,2003-01-22T04:59:59Z,2008-04-12T01:17:07Z,,0,0,0900006480492511